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ABSTRACT
Glycyrrhizin is a bioactive natural glycoside. Glycyrrhetic acid is an aglycone and an active metabolite of glycyrrhizin. The antiinflammatory activity of glycyrrhetic acid is even stronger than that of glycyrrhizin and glycyrrhetic acid is responsible for the adverse
effect of aldosteronism. This study attempted to compare the pharmacokinetics of glycyrrhetic acid after oral administration of equal molar
doses of glycyrrhizin and glycyrrhetic acid to rabbits.
Six New Zealand White rabbits were orally given glycyrrhizin or glycyrrhetic acid at a dose of 178.5 µmol kg-1 in a randomized
crossover design. HPLC methods were used to determine the serum concentrations of glycyrrhizin and glycyrrhetic acid. A noncompartment model was used to calculate the pharmacokinetic parameters and a paired Student’s t-test was used for statistical comparison.
The results indicated that in addition to the absorption of glycyrrhizin per se at small intestine, oral dosing of glycyrrhizin resulted in
higher AUC0-t and MRT of glycyrrhetic acid by 443 % and 354 %, respectively, than those after oral dosing of glycyrrhetic acid. It can be
concluded that glycyrrhizin is a good prodrug of glycyrrhetic acid.
Key words: glycyrrhizin, glycyrrhetic acid, pharmacokinetics

INTRODUCTION
Glycyrrhizin is a major and active constituent of the root
of Glycyrriza uralensis FISCH (licorice) which is the most
common herb used in traditional Chinese medicine.
Glycyrrhizin possesses various pharmacological effects and
has been used for the treatment of chronic hepatitis, inflammation, gastric ulcers and immunodeficiency virus infection(1-4). Overconsumption of glycyrrhizin can produce the
adverse effect of aldosteronism(5). Glycyrrhetic acid is an
aglycone and an active metabolite of glycyrrhizin.
Glycyrrhetic acid was reported to be responsible for the toxic
effect of aldosteronism(6). The oral pharmacokinetics of glycyrrhetic acid and the comparison with the pharmacokinetics
of glycyrrhizin have not been reported in the literature.
Therefore, in the present study we attempted to characterize
the oral pharmacokinetics of glycyrrhetic acid and furthermore, to compare the pharmacokinetics of glycyrrhetic acid
after oral administrations of equal molar doses of glycyrrhizin and glycyrrhetic acid to rabbits.

MATERIALS AND METHODS
I. Chemicals and Reagents
Glycyrrhizin, propylparaben and glycofurol were purchased from Sigma Chemical Company (St Louis, MO,
USA). Glycyrrhetic acid and 2-methylanthraquinone were
products of Aldrich Chemical Company Inc.. All other chem* Author for correspondence. Tel: 04-22053366 ext. 1905;
Fax: 04-22031028; E-mail: pdlee@mail.cmc.edu.tw

icals and solvents used were of analytical grade or HPLC
quality. Milli-Q plus water (Millipore, Bedford, MA, USA)
was used for all preparations.
II. Animals
Six male New Zealand white rabbits, weighing 2.1 ~ 3.2
kg, were used throughout this study. Animals were housed in
a 12-hr light-dark, constant temperature environment prior to
study. All rabbits were fasted for 1 day before the experiment. Water was supplied ad libitum.
III. Pharmacokinetic Analysis
The pharmacokinetic experiments were performed with
six rabbits in a randomized crossover design. Glycyrrhizin
was given orally as an aqueous solution at a dose of 150 mg
kg-1 (178.5 µmol kg-1) and glycyrrhetic acid was given orally
as a solution in glycofurol at a dose of 84 mg kg-1 (178.5
µmol kg-1). Drug administration was carried out via gastric
gavage throughout the study. One week was allowed for
wash-out.
Blood samples (1.2 mL) were withdrawn via the right
ear vein at 0, 1, 2, 4, 6, 8, 10, 12, 24, 36 and 48 hr after glycyrrhizin administration and at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3,
4, 6 and 8 hr after glycyrrhetic acid administration. All blood
samples were centrifuged for 15 min at 9860 x g and the
serum samples obtained were stored at -30˚C until analysis.
VI. Quantitation of Glycyrrhizin and Glycyrrhetic Acid in
Serum
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Twenty µL of glycyrrhizin solution of appropriate concentrations was spiked into 180 µL serum to afford serum
standards with concentrations of 1.2, 2.5, 5.0, 10.0, 20.0, and
50.0 µg mL-1. To 200 µL of serum standards, 800 µL of
methanol containing 0.12 µg mL-1 of propylparaben as the
internal standard was added for deproteinization. The mixture was vortexed for 30 sec and centrifuged at 9860 x g for
15 min, the supernatant was removed and evaporated to dryness by blowing nitrogen. The residue was reconstituted with
50 µL of mobile phase (acetonitrile: 1% acetic acid = 36: 64),
of which 20 µL was subjected to HPLC analysis. The peak
ratios (glycyrrhizin to propylparaben) of serum standard
were determined in duplicate. The calibration curve was calculated by linear regression of the peak-area ratios against
concentrations of glycyrrhizin.
Thirty µL of glycyrrhetic acid solution of appropriate
concentrations was spiked into 270 µL serum to afford serum
standards with concentrations of 0.1, 0.2, 0.5, 1.0, 2.0, 4.0
and 8.0 µg mL-1. To 300 µL of serum, 100 µL of 0.1N HCl
was added, then partitioned with 400 µL of ethyl acetate containing 0.1 µg mL-1 of 2-methylanthraquinone as the internal
standard. The later process followed that for glycyrrhizin.
The peak ratios (glycyrrhetic acid to 2-methylanthraquinone)
of serum standards were determined in duplicate. The calibration curve was calculated by linear regression of the peakarea ratios against concentrations of glycyrrhetic acid.
V. Quantitation of Glycyrrhetic Acid Mono-β-D-glucuronide
Three hundred µL of each serum sample after oral dosing of glycyrrhetic acid was subjected to glycyrrhetic acid
quantitation before and after hydrolysis by β-glucuronidase
at 37˚C shaking water bath. For the detection of glycyrrhetic
acid mono-β-D-glucuronide, glycyrrhetic acid concentrations in the serum before and after enzymatic hydrolysis were
compared.
VI. HPLC Conditions
The HPLC apparatus included one pump (LC-10AS,
Shimadzu, Japan) and an UV-VIS detector (SPD-10A,
Shimadzu, Japan). The assay employed a LiChrospher 100
RP-18e column (4.0 × 250 mm, 5 µm, Merck). The UV
detector was set at 248 nm and the flow rate was 1.0 mL
min-1. Chromatographic separation was achieved by using a
mobile phase consisting of acetonitrile and 1% acetic acid
(36:64, v/v) for glycyrrhizin determination. As for the assay
of glycyrrhetic acid and 3-dehydroglycyrrhetic acid, a mobile
phase consisting of acetonitrile and 1% acetic acid (67:33,
v/v) was used.

spiking glycyrrhizin and glycyrrhetic acid into blank serum
and water in triplicates to afford 5.0, 10.0, 50.0 and 0.5, 1.0,
4.0 µg mL-1, respectively, and the concentrations obtained in
blank serum to the corresponding ones in water were compared. LOQ (Limit of Quantitation) represents the lowest
concentration of analyte in a sample that can be determined
with acceptable precision and accuracy, whereas LOD (Limit
of Detection) represents the lowest concentration of analyte
in a sample that can be detected (with S/N > 3).
VIII. Data Analysis
The glycyrrhizin and glycyrrhetic acid serum concentration-time data were analyzed by noncompartment method
with the aid of the program WINNONLIN (version 1.1, SCI
software, Statistical Consulting, Inc., Apex, NC). The peak
plasma concentration (Cmax) and the time to peak concentration (Tmax) were obtained from experimental observations.
The paired Student's t-test was used for statistical comparison
of pharmacokinetic parameters.

RESULTS AND DISCUSSION
Typical chromatograms of glycyrrhizin and glycyrrhetic
acid are shown in Figure 1. Good linear relationships were
obtained for glycyrrhizin and glycyrrhetic acid over the concentration ranges of 1.2 - 50.0 µg mL-1 (Y = 0.194 X - 0.025,
r = 0.999) and 0.1 - 8.0 µg mL-1 (Y = 1.016 X + 0.008, r =
0.999), respectively. The precision and accuracy of these
methods are shown in Table 1 and Table 2. The LOQ (limit of
quantitation) of glycyrrhizin and glycyrrhetic acid were 1.2
µg mL-1 and 0.1 µg mL-1, respectively. The LOD (limit of
detection) of glycyrrhizin and glycyrrhetic acid were 0.30 µg
mL-1 and 0.04 µg mL-1, respectively. The LOQ and LOD of
glycyrrhizin were about 10 times of glycyrrhetic acid. This is
due to the higher molar extinction coefficient and lower molecular weight of glycyrrhetic acid than those of glycyrrhizin.
The recoveries of glycyrrhizin and glycyrrhetic acid were
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VII. Validation of Assay Methods
The precision and accuracy of those assay methods were
evaluated by intra-day and inter-day analysis of triplicate
serum standards over a period of three days. The accuracy of
this method was further assessed with recovery studies by
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Figure 1. HPLC chromatograms of (A): glycyrrhizin (a, 6.4 µg mL-1)
with propylparaben (b) and (B): glycyrrhetic acid (d, 1.5 µg mL-1) with
2-methylanthraquinone (c) in serum sample.
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Table 1. Intraday and interday analytical precision and accuracy of glycyrrhizin determination in rabbit serum
Intraday (n=3)
Interday (n=3)
Concentration
Precision
Accuracy
Precision
Accuracy
(µg mL-1)
Mean ± S.D. (C.V.%)
R. E.(%)
Mean ± S.D. (C.V.%)
R. E. (%)
50.0
50.6 ± 0.4 (0.8)
1.2
50.7 ± 1.7 (3.3)
1.3
-2.6
19.9 ± 0.6 (2.9)
-0.3
20.0
19.5 ± 0.4 (2.2)
-2.3
10.0 ± 0.2 (1.8)
0.4
10.0
9.8 ± 0.02 (0.2)
-0.1
5.1 ± 0.1 (1.5)
1.4
5.0
5.0 ± 0.01 (0.3)
4.2
2.6 ± 0.05 (2.0)
2.0
2.5
2.6 ± 0.03 (1.1)
1.2
1.3 ± 0.01 (0.8)
4.4
1.3 ± 0.04 (3.0)
3.7

Table 2. Intraday and interday analytical precision and accuracy of glycyrrhetic acid assay in serum
Intraday (n=3)
Interday (n=3)
Concentration
Precision
Accuracy
Precision
Accuracy
(µg mL-1)
Mean ± S.D. (C.V.%)
R. E. (%)
Mean ± S.D. (C.V.%)
R. E. (%)
-9.3
7.7 ± 0.4 (4.8)
-4.3
8.0
7.2 ± 0.01 (0.1)
-0.1
4.3 ± 0.2 (5.3)
6.7
4.0
4.0 ± 0.01 (0.3)
1.6
2.2 ± 0.1 (6.2)
7.4
2.0
2.0 ± 0.02 (1.0)
-2.2
1.0 ± 0.04 (3.8)
-1.6
1.0
1.0 ± 0.04 (3.6)
-0.1
0.5 ± 0.01 (1.2)
-1.3
0.5
0.5 ± 0.00 (0.2)
-1.3
0.3 ± 0.01 (4.8)
4.8
0.2
0.2 ± 0.00 (0.5)
0.1
0.1 ± 0.00 (3.9)
2.1
0.1 ± 0.01 (6.1)
12.1

Table 3. Recoveries (%) of glycyrrhizin and glycyrrhetic acid from
serum (n=3)
Constituents spiked
Concentration
Recoveries
(µg mL-1)
(Mean ± S.E.) (%)
5.0
108.0 ± 4.6
Glycyrrhizin
10.0
100.7 ± 0.4
50.0
112.9 ± 4.9
0.5
100.2 ± 5.2
Glycyrrhetic acid
1.0
97.9 ± 2.7
4.0
112.8 ± 3.1

100.7 - 112.9% and 97.9 - 112.8%, respectively, as listed in
Table 3.
The profiles of mean serum concentrations of glycyrrhizin and glycyrrhetic acid after glycyrrhizin administration are shown in Figure 2 and the pharmacokinetic parameters of glycyrrhizin and glycyrrhetic acid are listed in Table 4.
The mean Tmax of glycyrrhizin and glycyrrhetic acid after glycyrrhizin administration were 2.8 and 7.0 hr, respectively.
Because the elimination rate constants of some rabbits could
not be estimated, therefore, AUC0-t was calculated instead of
AUC0-∞. The AUC0-t of glycyrrhizin and glycyrrhetic acid
after glycyrrhizin administration were 47.9 and 16.3 µg mL-1
hr (57.0 and 34.6 nmol mL-1 hr), respectively. The mean
MRT of glycyrrhizin and glycyrrhetic acid after glycyrrhizin
administration were about 4.8 and 12.7 hr, respectively.
After glycyrrhizin administration, glycyrrhetic acid,
glycyrrhetic acid mono-β-D-glucuronide, 3-dehydroglycyrrhetic acid and 3α-glycyrrhetic acid appearing in the plasma of rats and humans were metabolized from glycyrrhizin
by both the intestinal bacteria and various organs(7). In this
study, only glycyrrhizin and glycyrrhetic acid were determined in rabbit serum, whereas glycyrrhetic acid mono-β-Dglucuronide, 3-dehydroglycyrrhetic acid and 3α-glycyrrhetic
acid were not detected. However, 3-dehydroglycyrrhetic acid

Figure 2. Mean serum concentration-time profiles (± S.E.) of glycyrrhizin (closed circles) and glycyrrhetic acid (closed triangles) after
oral administration of glycyrrhizin (150 mg kg-1) and glycyrrhetic acid
(open triangles) after oral administration of glycyrrhetic acid (84 mg
kg-1) to six rabbits.

has been detected as a metabolite of glycyrrhizin when glycyrrhizin was incubated in fresh rabbit feces in an in vitro
study in our laboratory (data not shown). The serum level of
3-dehydroglycyrrhetic acid may be too low to be detected.
Imai et al.(8) reported that the hydrolysis of glycyrrhizin to
glycyrrhetic acid mono-β-D-glucuronide was extremely slow
and glycyrrhetic acid mono-β-D-glucuronide was rapidly
transformed to glycyrrhetic acid. Therefore, a blood profile
of glycyrrhetic acid mono-β-D-glucuronide was never reported by any pharmacokinetic studies of glycyrrhizin. Our
results indicated that glycyrrhizin could be absorbed per se
and in its main metabolite form - glycyrrhetic acid from gut
in rabbits, which was similar to the fates of glycyrrhizin upon
oral administration to rats and humans(9,10). Our results
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Table 4. Pharmacokinetic parameters of glycyrrhizin or glycyrrhetic acid after oral administration of glycyrrhizin (150 mg kg-1) and glycyrrhetic
acid (84 mg kg-1), respectively, to six rabbits
Drug administered
Glycyrrhizin
Glycyrrhetic acid
Parameters
Glycyrrhizin
Glycyrrhetic acid
Glycyrrhetic acid
Tmaxa (hr)
2.8 ± 0.7
7.0 ± 1.0
1.7 ± 0.7**
6.7 ± 1.4
1.6 ± 0.3
1.3 ± 0.3
Cmaxb (µg mL-1)
47.9 ± 17.9
16.3 ± 2.7
3.0 ± 0.5**
AUCc (µg mL-1 hr)
MRTd (hr)
4.8 ± 1.1
12.7 ± 2.1
2.8 ± 0.3**
a time of peak plasma level.
b concentration of peak plasma level.
Data is expressed as mean ± S.E.
c area under plasma concentration - time curve to the last point.
d mean residence time.
** p<0.01.

showed that Tmax and MRT of glycyrrhizin were 2.8 hr and
4.8 hr, whereas those of glycyrrhetic acid were 7.0 hr and
12.7 hr, respectively, indicating glycyrrhetic acid was
absorbed at a later phase and stayed longer in the body than
glycyrrhizin. This is consistent with the previous finding in
rats by Wang et al.(11) who stated that glycyrrhizin was
absorbed through the small intestine and the unabsorbed glycyrrhizin was hydrolyzed by bacteria in the large intestine.
Thus, most of the glycyrrhetic acid metabolized from glycyrrhizin was absorbed from the large intestine. The Cmax and
AUC0-t of glycyrrhizin (6.7 µg mL-1, 47.9 µg mL-1 hr) were
much higher than those of glycyrrhetic acid (1.6 µg mL-1,
16.3 µg mL-1 hr). However, the in vivo anti-inflammatory
activity of glycyrrhetic acid was shown to be 10 to 50 times
higher than that of glycyrrhizin(12), therefore, in terms of
therapeutic consequence, glycyrrhetic acid might be more
important than glycyrrhizin although the serum levels were
much lower for glycyrrhetic acid.
The profile of mean serum glycyrrhetic acid concentration after glycyrrhetic acid administration is also shown in
Figure 2 and the pharmacokinetic parameters of glycyrrhetic
acid are listed in Table 4. The mean Tmax of glycyrrhetic acid
after glycyrrhetic acid administration was about 1.7 hr. The
AUC0-t of glycyrrhetic acid after glycyrrhetic acid administration was 3.0 µg mL-1 hr (6.4 nmol mL-1 hr). The mean
MRT of glycyrrhetic acid was 2.8 hr.
After glycyrrhetic acid administration, the presence of
its conjugate metabolite - glycyrrhetic acid mono-β-D-glucuronide in serum has been investigated by comparing the
concentrations of glycyrrhetic acid in serum samples before
and after hydrolysis with β-D-glucuronidase. No significant
increase of glycyrrhetic acid concentration was found upon
hydrolysis. Therefore, it is proposed that a negligible amount
of glycyrrhetic acid mono-β-D-glucuronide was circulating
in plasma after oral dosing of glycyrrhetic acid. It revealed
that the metabolic fate of the alcohol group was quite different from that of the phenolic group.
In order to compare the pharmacokinetic behavior
between glycoside and its aglycone, this study carried out a
comparison of glycyrrhizin and glycyrrhetic acid based on
giving equal molar doses to six rabbits in a crossover design.
The results showed that the AUC0-t of glycyrrhetic acid after
oral dosing of glycyrrhizin were significantly greater than
those after oral dosing of glycyrrhetic acid by 443%. The
smaller exposure of glycyrrhetic acid after oral dosing of glycyrrhetic acid compared to that after oral dosing of equal

molar glycyrrhizin can be explained by the less water solubility of glycyrrhetic acid in the gastrointestinal tract. The
Tmax of glycyrrhetic acid after oral dosing of glycyrrhizin
occurred at 7.0 hr, which was about 5.3 hr later than that after
oral dosing of glycyrrhetic acid. This was in good agreement
with the fact that glycyrrhizin was metabolized gradually into
glycyrrhetic acid by various organs and by enterobacteria in
the large intestine where most glycyrrhetic acid was absorbed
when glycyrrhizin was orally administered, whereas glycyrrhetic acid was mainly absorbed in the small intestine
when glycyrrhetic acid was orally administered(7). In contrast
to the MRT of glycyrrhetic acid (2.8 hr) after oral dosing of
glycyrrhetic acid, the MRT of glycyrrhetic acid (12.7 hr) after
oral administration of glycyrrhizin was 354 % longer, indicating that glycyrrhizin was serving like a sustained - release
dosage form of glycyrrhetic acid. The metabolite glycyrrhetic acid was formed from glycyrrhizin gradually and then
absorbed thereafter. It can be concluded that in addition to the
absorption of its parent form, glycyrrhizin is an even better
prodrug of glycyrrhetic acid than glycyrrhetic acid itself,
because it revealed higher exposure of glycyrrhetic acid and
lasted for longer residence time.
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甘草酸與甘草次酸於兔體內之動力學比較
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摘

要

甘草酸為一具生物活性之天然配醣體，甘草次酸為其非醣體及活性代謝物。甘草次酸之抗炎活性較甘草
酸為強，亦為副作用醛類脂醇過多症之主因，本研究之目的為比較家兔口服等莫耳之甘草酸與甘草次酸後，
其甘草次酸藥物動力學之差異。
六隻紐西蘭大白兔以隨機交叉設計，口服給予 178.5 µmol kg-1 之甘草酸或甘草次酸後，以高效液相層析
法測定血中甘草酸與甘草次酸之濃度；採用非室性模式計算動力學參數並用 paired Student’s t-test 比較其統計
上之差異。
結果顯示口服甘草酸時，除了先有甘草酸原形於小腸吸收外，其代謝物甘草次酸的曲線下面積及平均滯
留時間與口服甘草次酸相比較，顯著增加了 443% 及 354% 。因此，甘草酸可視為甘草次酸之極佳前驅藥。
關鍵詞：甘草酸，甘草次酸，藥物動力學

